MYRIAD GENETICS INC — Director's Dealing 2019

Aug 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2019-08-01

Reporting Person: Capone Mark Christopher (President & C.E.O.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-01	Common Stock	M	70672	$23.11	Acquired	511505	Direct
2019-08-01	Common Stock	S	70672	$44.0	Disposed	440833	Direct
2019-08-01	Common Stock	M	4328	$23.11	Acquired	445161	Direct
2019-08-01	Common Stock	S	4328	$44.0	Disposed	440833	Direct
2019-08-01	Common Stock	M	58138	$30.34	Acquired	498971	Direct
2019-08-01	Common Stock	S	58138	$44.0	Disposed	440833	Direct
2019-08-01	Common Stock	M	3862	$30.34	Acquired	444695	Direct
2019-08-01	Common Stock	S	3862	$44.0	Disposed	440833	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-01	Incentive Stock Option (right to buy)	$23.11	M	4328	Disposed	2020-03-03	Common Stock (4328)	Direct
2019-08-01	Incentive Stock Option (right to buy)	$30.34	M	3862	Disposed	2019-09-15	Common Stock (3862)	Direct
2019-08-01	Non-Qualified Stock Option (right to buy)	$23.11	M	70672	Disposed	2020-03-03	Common Stock (70672)	Direct
2019-08-01	Non-Qualified Stock Option (right to buy)	$30.34	M	58138	Disposed	2019-09-15	Common Stock (58138)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.